213 related articles for article (PubMed ID: 8096058)
1. A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells.
Scott GK; Robles R; Park JW; Montgomery PA; Daniel J; Holmes WE; Lee J; Keller GA; Li WL; Fendly BM
Mol Cell Biol; 1993 Apr; 13(4):2247-57. PubMed ID: 8096058
[TBL] [Abstract][Full Text] [Related]
2. c-erbB3 gene encodes secreted as well as transmembrane receptor tyrosine kinase.
Katoh M; Yazaki Y; Sugimura T; Terada M
Biochem Biophys Res Commun; 1993 May; 192(3):1189-97. PubMed ID: 7685162
[TBL] [Abstract][Full Text] [Related]
3. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.
Aigner A; Juhl H; Malerczyk C; Tkybusch A; Benz CC; Czubayko F
Oncogene; 2001 Apr; 20(17):2101-11. PubMed ID: 11360194
[TBL] [Abstract][Full Text] [Related]
4. A 1.8 kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptor.
Reiter JL; Maihle NJ
Nucleic Acids Res; 1996 Oct; 24(20):4050-6. PubMed ID: 8918811
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing.
Rodrigues GA; Naujokas MA; Park M
Mol Cell Biol; 1991 Jun; 11(6):2962-70. PubMed ID: 1710022
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of hepatocyte growth factor receptor-IgG fusion proteins. Effects of mutations in the potential proteolytic cleavage site on processing and ligand binding.
Mark MR; Lokker NA; Zioncheck TF; Luis EA; Godowski PJ
J Biol Chem; 1992 Dec; 267(36):26166-71. PubMed ID: 1334493
[TBL] [Abstract][Full Text] [Related]
7. An alternatively processed mRNA from the avian c-erbB gene encodes a soluble, truncated form of the receptor that can block ligand-dependent transformation.
Flickinger TW; Maihle NJ; Kung HJ
Mol Cell Biol; 1992 Feb; 12(2):883-93. PubMed ID: 1732751
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu.
Benz CC; Scott GK; Sarup JC; Johnson RM; Tripathy D; Coronado E; Shepard HM; Osborne CK
Breast Cancer Res Treat; 1992; 24(2):85-95. PubMed ID: 8095168
[TBL] [Abstract][Full Text] [Related]
9. Heregulin activation of extracellular acidification in mammary carcinoma cells is associated with expression of HER2 and HER3.
Chan SD; Antoniucci DM; Fok KS; Alajoki ML; Harkins RN; Thompson SA; Wada HG
J Biol Chem; 1995 Sep; 270(38):22608-13. PubMed ID: 7673253
[TBL] [Abstract][Full Text] [Related]
10. A truncated, secreted form of the epidermal growth factor receptor is encoded by an alternatively spliced transcript in normal rat tissue.
Petch LA; Harris J; Raymond VW; Blasband A; Lee DC; Earp HS
Mol Cell Biol; 1990 Jun; 10(6):2973-82. PubMed ID: 2342466
[TBL] [Abstract][Full Text] [Related]
11. Isoforms of the met receptor tyrosine kinase.
Rodrigues GA; Park M
EXS; 1993; 65():167-79. PubMed ID: 8380736
[TBL] [Abstract][Full Text] [Related]
12. Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast-cancer cells.
Lehtola L; Partanen J; Sistonen L; Korhonen J; Wärri A; Härkönen P; Clarke R; Alitalo K
Int J Cancer; 1992 Feb; 50(4):598-603. PubMed ID: 1311287
[TBL] [Abstract][Full Text] [Related]
13. Humanization of an anti-p185HER2 antibody for human cancer therapy.
Carter P; Presta L; Gorman CM; Ridgway JB; Henner D; Wong WL; Rowland AM; Kotts C; Carver ME; Shepard HM
Proc Natl Acad Sci U S A; 1992 May; 89(10):4285-9. PubMed ID: 1350088
[TBL] [Abstract][Full Text] [Related]
14. Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cells.
Scott GK; Daniel JC; Xiong X; Maki RA; Kabat D; Benz CC
J Biol Chem; 1994 Aug; 269(31):19848-58. PubMed ID: 7914192
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues.
Lee H; Maihle NJ
Oncogene; 1998 Jun; 16(25):3243-52. PubMed ID: 9681822
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms.
Reiter JL; Threadgill DW; Eley GD; Strunk KE; Danielsen AJ; Sinclair CS; Pearsall RS; Green PJ; Yee D; Lampland AL; Balasubramaniam S; Crossley TD; Magnuson TR; James CD; Maihle NJ
Genomics; 2001 Jan; 71(1):1-20. PubMed ID: 11161793
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase.
Maroc N; Rottapel R; Rosnet O; Marchetto S; Lavezzi C; Mannoni P; Birnbaum D; Dubreuil P
Oncogene; 1993 Apr; 8(4):909-18. PubMed ID: 8384358
[TBL] [Abstract][Full Text] [Related]
18. Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor).
Mondino A; Giordano S; Comoglio PM
Mol Cell Biol; 1991 Dec; 11(12):6084-92. PubMed ID: 1658624
[TBL] [Abstract][Full Text] [Related]
19. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein.
Ross RJ; Esposito N; Shen XY; Von Laue S; Chew SL; Dobson PR; Postel-Vinay MC; Finidori J
Mol Endocrinol; 1997 Mar; 11(3):265-73. PubMed ID: 9058373
[TBL] [Abstract][Full Text] [Related]
20. In vitro translation of a 2.3-kb splicing variant of the hamster pgp1 gene whose presence in transfectants is associated with decreased drug resistance.
Ma JF; Grant G; Staelens B; Howard DL; Melera PW
Cancer Chemother Pharmacol; 1999; 43(1):19-28. PubMed ID: 9923537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
